Kunnimalaiyaan, Selvi <br/><br/>
Xanthohumol-Mediated Suppression of Notch1 Signaling Is Associated with Antitumor Activity in Human Pancreatic Cancer Cells.  [electronic resource] 

 -  Molecular cancer therapeutics  Jun 2015 
 - 1395-403 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1538-8514 
<br/><br/><label>Standard No.: </label>10.1158/1535-7163.MCT-14-0915  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--pharmacology<br/>Apoptosis--drug effects<br/>Basic Helix-Loop-Helix Transcription Factors--genetics<br/>Blotting, Western<br/>Cell Line<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Cell Survival--drug effects<br/>Dose-Response Relationship, Drug<br/>Flavonoids--pharmacology<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Homeodomain Proteins--genetics<br/>Humans<br/>Inhibitor of Apoptosis Proteins--genetics<br/>Pancreatic Neoplasms--genetics<br/>Propiophenones--pharmacology<br/>Receptor, Notch1--genetics<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>Signal Transduction--drug effects<br/>Survivin<br/>Time Factors<br/>Transcription Factor HES-1<br/>Tumor Stem Cell Assay